Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-11-056422
Filing Date
2011-03-04
Accepted
2011-03-04 17:17:53
Documents
7
Period of Report
2010-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 1272473
2 2011 CORPORATE BONUS PLAN dex1011.htm EX-10.11 47885
3 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM dex231.htm EX-23.1 1702
4 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO RULE 13A-14(A)AND 15D-14(A) dex311.htm EX-31.1 9585
5 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO RULE 13A-14(A)AND 15D-14(A) dex312.htm EX-31.2 9762
6 CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER dex321.htm EX-32.1 5938
7 GRAPHIC g155933g96i73.jpg GRAPHIC 64472
  Complete submission text file 0001193125-11-056422.txt   1437319
Mailing Address 12481 HIGH BLUFF DRIVE SUITE 200 SAN DIEGO CA 92130
Business Address 12481 HIGH BLUFF DRIVE SUITE 200 SAN DIEGO CA 92130 8584361400
CADENCE PHARMACEUTICALS INC (Filer) CIK: 0001333248 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33103 | Film No.: 11665687
SIC: 2834 Pharmaceutical Preparations